Lowell Sears

Lowell Sears

Director Ejecutivo en
Sears Capital Management, Inc.
.
75 años
Health Technology
Consumer Services
Energy Minerals

Perfil

Mr. Lowell E.
Sears
is Chairman at Cellerant Therapeutics, Inc. and Founder, Chairman & Chief Executive Officer at Sears Capital Management, Inc. He is on the Board of Directors at SymBio Pharmaceuticals Ltd and Chief Investment Officer at Sears Capital Management, Inc. Prior to founding Sears Capital Management, Inc. in April 1994, Mr. Sears was employed as a Principal by Peninsula Pharmaceuticals, Inc., Chairman by Elitra Pharmaceuticals, Inc., Chief Financial Officer by Amgen, Inc., and Chief Financial Officer by Atlantic Richfield Co. He also served on the board at Asthmatx, Inc., Novacea, Inc., Novalar Pharmaceuticals, Inc., Coapt Systems, Inc., Dendreon Corp., CoCensys, Inc., Neose Technologies, Inc., Techne Corp., Corthera, Inc., and InteKrin Therapeutics, Inc. Mr. Sears received his degree in Economics from Claremont McKenna College and his MBA from Stanford University.

Cargos activos de Lowell Sears

EmpresasCargoInicio
Director Ejecutivo 01/04/1994
Director/Miembro de la Junta 01/04/2014

Antiguos cargos conocidos de Lowell Sears.

EmpresasCargoFin
Director/Miembro de la Junta 12/04/2019
Presidente 01/03/2017
SYMBIO PHARMACEUTICALS LIMITED Director/Miembro de la Junta 01/03/2017
Presidente 01/01/2017
Director/Miembro de la Junta 18/05/2011
Ver el detalle de la experiencia de Lowell Sears.

Formación de Lowell Sears.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

75

Relaciones de 1er grado

22

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas22

Health Technology

Energy Minerals

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Consumer Services

Health Technology

Health Services

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN